Prelude Capital Management LLC purchased a new stake in Molina Healthcare, Inc. (NYSE:MOH – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 970 shares of the company’s stock, valued at approximately $259,000.
A number of other institutional investors have also modified their holdings of MOH. Price T Rowe Associates Inc. MD raised its position in shares of Molina Healthcare by 59.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,787,368 shares of the company’s stock worth $1,013,084,000 after purchasing an additional 1,413,257 shares during the period. Vanguard Group Inc. increased its position in Molina Healthcare by 18.4% in the first quarter. Vanguard Group Inc. now owns 6,449,375 shares of the company’s stock worth $2,151,448,000 after buying an additional 1,001,372 shares during the period. Wellington Management Group LLP increased its position in Molina Healthcare by 40.4% in the first quarter. Wellington Management Group LLP now owns 2,603,321 shares of the company’s stock worth $696,362,000 after buying an additional 749,696 shares during the period. Norges Bank acquired a new stake in Molina Healthcare in the fourth quarter worth $214,801,000. Finally, Durable Capital Partners LP acquired a new stake in Molina Healthcare in the first quarter worth $214,363,000. Institutional investors own 98.11% of the company’s stock.
Insider Buying and Selling at Molina Healthcare
In other news, CAO Maurice Hebert sold 692 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $328.15, for a total transaction of $227,079.80. Following the transaction, the chief accounting officer now directly owns 8,528 shares in the company, valued at approximately $2,798,463.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, Director Barbara L. Brasier sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $303.89, for a total value of $455,835.00. Following the completion of the sale, the director now owns 3,232 shares of the company’s stock, valued at approximately $982,172.48. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Maurice Hebert sold 692 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $328.15, for a total transaction of $227,079.80. Following the transaction, the chief accounting officer now directly owns 8,528 shares in the company, valued at $2,798,463.20. The disclosure for this sale can be found here. Insiders have sold a total of 17,938 shares of company stock valued at $5,474,336 in the last 90 days. 1.10% of the stock is currently owned by corporate insiders.
Molina Healthcare Trading Up 0.4 %
Molina Healthcare (NYSE:MOH – Get Free Report) last posted its quarterly earnings results on Wednesday, July 26th. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.05 by $0.60. The firm had revenue of $8.33 billion for the quarter, compared to analyst estimates of $8.32 billion. Molina Healthcare had a net margin of 2.81% and a return on equity of 35.87%. The firm’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $4.55 earnings per share. On average, research analysts predict that Molina Healthcare, Inc. will post 20.78 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have weighed in on MOH. StockNews.com raised Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Friday. Cantor Fitzgerald restated an “overweight” rating and issued a $359.00 price target on shares of Molina Healthcare in a research note on Thursday, September 14th. Bank of America raised their price target on shares of Molina Healthcare from $340.00 to $350.00 in a research note on Thursday, July 27th. UBS Group assumed coverage on shares of Molina Healthcare in a research note on Tuesday, June 20th. They issued a “neutral” rating and a $310.00 price target on the stock. Finally, JPMorgan Chase & Co. lowered their price target on Molina Healthcare from $348.00 to $341.00 in a report on Friday, July 7th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $351.31.
About Molina Healthcare
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
- Five stocks we like better than Molina Healthcare
- The How and Why of Investing in Gold Stocks
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- The 3 Best Fintech Stocks to Buy Now
- 5 Reasons Mullen Automotive is About to Turn a Corner
- Basic Materials Stocks Investing
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.